Jun 28, 2026, 14:00 UTC
Novo Nordisk A/S (B Shares) ADRhedged disclosed a quarterly dividend of $0.7667 per share, paid on June 23rd to shareholders of record on June 16th, representing an annualized dividend of $3.07 and a yield of 11.7%.
Source:Jun 18, 2026, 19:51 UTC
Novo Nordisk confirmed a data breach where hackers spent two months inside its systems and stole clinical trial data and AI models.
Source:Jun 15, 2026, 11:17 UTC
Novo Nordisk disclosed that hackers breached its IT systems and accessed personal data.
Source:Jun 11, 2026, 15:30 UTC
Novo Nordisk A/S identified an IT security incident involving unauthorized access to a limited number of internal IT systems.
Jun 9, 2026, 13:35 UTC
AstraZeneca reported encouraging mid-stage trial results for its experimental weight-loss pill elecoglipron, showing 11.8% weight loss after 36 weeks.
Jun 2, 2026, 21:43 UTC
Cigna drops coverage of GLP-1 obesity drugs for its own employees effective July 1.
Source:Jun 1, 2026, 11:17 UTC
Novo Nordisk initiated a share repurchase programme on 6 May 2026 as part of a larger programme of up to DKK 15 billion over 12 months from 4 February 2026.
← PreviousPage 3